SCHEMBL19862243

SCHEMBL19862243

C1=Cc2ccc(-c3cc(-c4ccccc4)nc(-c4ccc(-c5cccnc5)cc4)n3)cc2C2(c3ccccc31)c1ccccc1-c1c2ccc2oc3ccccc3c12

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.35
PDK2 Q15119 3/20 0.34
CYP19A1 P11511 1/20 0.32
ALDH1A1 P00352 2/20 0.31
NPSR1 Q6W5P4 2/20 0.31
MEN1 O00255 1/20 0.31
MAPT P10636 1/20 0.31
TSHR P16473 1/20 0.31
ALOX12 P18054 1/20 0.31
MAPK1 P28482 1/20 0.31
KMT2A Q03164 1/20 0.31
HSD17B10 Q99714 1/20 0.31
PIM1 P11309 1/20 0.31
PIM2 Q9P1W9 1/20 0.31
KDM4E B2RXH2 1/20 0.31
GLA P06280 1/20 0.31
GAA P10253 1/20 0.31
LMNA P02545 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19862246 1.00 DHODH (0.35) DHODHPDK2CYP19A1ALDH1A1NPSR1
SCHEMBL19862251 0.98 DHODH (0.36) DHODHPDK2CYP19A1ALDH1A1NPSR1
SCHEMBL19862242 0.97 PDK2 (0.35) DHODHPDK2CYP19A1ALDH1A1NPSR1
SCHEMBL19862247 0.96 PDK2 (0.35) DHODHPDK2CYP19A1ALDH1A1NPSR1
SCHEMBL19862240 0.96 PDK2 (0.35) DHODHPDK2CYP19A1ALDH1A1NPSR1
SCHEMBL19862248 0.93 PDK2 (0.33) DHODHPDK2CYP19A1ALDH1A1NPSR1
SCHEMBL19862238 0.93 KMT2A (0.33) ALDH1A1MEN1MAPTMAPK1KMT2A
SCHEMBL19862250 0.92 HDAC6 (0.33) DHODHPDK2CYP19A1
SCHEMBL19862255 0.92 HDAC6 (0.33) DHODHPDK2CYP19A1
SCHEMBL19862249 0.91 KMT2A (0.32) ALDH1A1MEN1MAPTMAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10454039-B2 Compound and organic electronic device using the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2019-10-22 US disclosed
US-20180047918-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2018-02-15 US disclosed
US-20180047918-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180047918-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME ORC3, AOX1, RCOR3 DHODH 1612/4885PDK2 2964/4885CYP19A1 371/4885
US-10454039-B2 Compound and organic electronic device using the same ORC3, AOX1, RCOR3 DHODH 1612/4885PDK2 2964/4885CYP19A1 371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.